Reklāma
Forex ziņas
Australia GDP Data Due On Wednesday
Australia will on Wednesday release Q2 figures for gross domestic product, headlining a busy day for Asia-Pacific economic activity. GDP is expected to expand 1.0 percent on quarter and 3.5 percent on year, accelerating from 0.8 percent on quarter and 3.3 percent on year in the three months prior.
RTTNews |
998 days ago
TSX Retreats After Positive Start, Ends Notably Lower
Canadian stocks fell swiftly after a positive start Tuesday morning, and then spent the rest of the day's session in the red to finally settle notably lower.
RTTNews
|
998 days ago
Dollar Rises Against Major Counterparts On Strong Service Sector Data
The U.S. dollar climbed higher on Tuesday, buoyed by data showing a slightly faster pace of growth of the nation's service sector in the month of August.
RTTNews
|
998 days ago
Swiss Market Ends Slightly Higher
Despite suffering a mild setback in the final hour, the Switzerland stock market ended on a slightly positive note on Tuesday.
RTTNews
|
998 days ago
Major European Markets Close Higher After Cautious Session
The major European markets closed slightly higher on Tuesday with investors largely making cautious moves. China's pledge to make renewed efforts to boost its Covid-hit economy helped underpin sentiment.
RTTNews
|
998 days ago
Canadian Market Slips After Positive Start, Modestly Lower At Noon
After opening on a positive note, the Canadian market retreated Tuesday morning, and is down in the red a little past noon, weighed down by losses in energy and healthcare sections.
RTTNews
|
998 days ago
U.S. Services Index Unexpectedly Indicates Slightly Faster Growth In August
Service sector activity in the U.S. unexpectedly grew at a slightly faster rate in the month of August, according to a report released by the Institute for Supply Management on Tuesday. The ISM said its services PMI inched up to 56.9 in August from 56.7 in July, with a reading above 50 indicating growth in the sector.
RTTNews
|
998 days ago
more news
Pound Advances As PM Liz Truss Finalizes Energy Support Package
The pound climbed against its most major counterparts in the European session on Tuesday, as U.K. Prime Minister Liz Truss is considering a support package worth 40 billion pounds in order to help businesses to lower their energy bills.
RTTNews
|
998 days ago
Adial Pharma Says Purnovate's PNV-6005 Reports Positive Data In Treating Ulcerative Colitis
Adial Pharmaceuticals, Inc. (ADIL) announced Tuesday that Purnovate, Inc., a subsidiary of Adial, achieved positive in-vivo data from its study with mice treated with Purnovate's PNV-6005 as a potential treatment for inflammatory bowel diseases.
RTTNews
|
998 days ago
Kaiser Aluminum Lifts Force Majeure At Warrick Rolling Mill
Kaiser Aluminum Corp. (KALU) announced Tuesday that it has lifted force majeure declared on July 7, 2022 at its Warrick Rolling Mill, due to limited availability of magnesium utilized in the production of certain of its aluminum beverage and food packaging products, reducing its ability to produce those products at that time.
RTTNews
|
998 days ago
Sarepta Therapeutics Says FDA Lifts Clinical Hold On SRP-5051 To Treat Duchenne Muscular Dystrophy
Genetic medicine maker Sarepta Therapeutics, Inc. (SRPT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on SRP-5051 (vesleteplirsen), the Company's investigational, next-generation peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) to treat patients with Duchenne muscular dystrophy who are amenable to exon 51 skipping.
RTTNews
|
998 days ago
Creatd Names Executive Chairman Jeremy Frommer As CEO
Creatd, Inc. (CRTD), a creator-first holding company, and the parent company of Vocal, announced Tuesday a new appointment to its board of directors, Justin Maury, Creatd COO and co-founder, as well as the appointment of current Executive Chairman, Jeremy Frommer to the position of Chairman and CEO.
RTTNews
|
998 days ago
Tenaya Therapeutics Says FDA Clears IND Application And Initiation Of Phase 1 For TN-301
Biotechnology company Tenaya Therapeutics, Inc. (TNYA) announced Tuesday the clearance of its Investigational New Drug (IND) application to begin clinical testing of TN-301 by the U.S. Food and Drug Administration (FDA).
RTTNews
|
998 days ago
Stay up to date!
Add News to your browser
Add To Chrome
